R S Bresalier Selected Research

Caspase 8 (Caspase-8)

3/2012

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R S Bresalier Research Topics

Disease

5	Neoplasms (Cancer) 01/2018 - 07/2000
2	Colonic Neoplasms (Colon Cancer) 03/2012 - 11/2000
2	Colorectal Neoplasms (Colorectal Cancer) 12/2000 - 07/2000
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Adenoma (Adenomas) 01/2018
1	Carcinogenesis 11/2014
1	Lymphatic Metastasis 11/2014
1	Stomach Neoplasms (Stomach Cancer) 11/2014
1	Lung Neoplasms (Lung Cancer) 12/2000
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2000
1	Ovarian Neoplasms (Ovarian Cancer) 12/2000
1	Prostatic Neoplasms (Prostate Cancer) 12/2000
1	Infections 06/2000

Drug/Important Bio-Agent (IBA)

3	Galectin 3 (LGALS3)IBA 11/2014 - 11/2000
2	LigandsIBA 03/2012 - 11/2000
2	MucinsIBA 11/2000 - 06/2000
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012
1	Death Domain ReceptorsIBA 03/2012
1	Caspase 8 (Caspase-8)IBA 03/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2000
1	Biological ProductsIBA 12/2000
1	Laminin (Merosin)IBA 11/2000

Therapy/Procedure

2	Chemoprevention 12/2000 - 07/2000